Filing Details

Accession Number:
0001209191-22-016529
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-04 21:00:26
Reporting Period:
2022-02-23
Accepted Time:
2022-03-04 21:00:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1655759 Arvinas Inc. ARVN Pharmaceutical Preparations (2834) 472566120
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1753537 G John Houston C/O Arvinas, Inc.
5 Science Park, 395 Winchester Ave.
New Haven CT 06511
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-04 17,511 $0.00 849,844 No 4 M Direct
Common Stock Disposition 2022-03-04 6,024 $63.94 843,820 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2022-02-23 200,500 $0.00 200,500 $64.19
Common Stock Restricted Stock Units Disposition 2022-03-04 17,511 $0.00 17,511 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
200,500 2032-02-22 No 4 A Direct
17,510 No 4 M Direct
Footnotes
  1. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
  2. This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
  3. The broker sold shares of the Issuer's common stock for certain employees following the vesting of previously granted Restricted Stock Units, including the common stock reported on this Form 4 by the reporting person, at an average price of $63.94.
  4. This option award was granted on February 23, 2022. 1/4 of the shares underlying the award shall vest on February 23, 2023, with the remainder of the shares vesting in equal monthly installments following February 23, 2023 through February 23, 2026.
  5. On March 1, 2019, the reporting person was granted 70,042 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020.